KRAS and lung cancer: To examine the effects of melatonin on lung cancer, human NSCLC cell lines including the H460 and A549, and mouse Lewis cell carcinoma LLC1 cell lines, which harbor KRAS mutations, were incubated with different concentrations of melatonin for 24 and 48 h.